<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="table1" position="float">
 <label>Table 1.</label>
 <caption>
  <title>Search terms and the number of studies included for each investigated drug group.</title>
 </caption>
 <table frame="border" rules="all">
  <thead>
   <tr>
    <th align="center" valign="middle" rowspan="1" colspan="1">Drug group</th>
    <th align="center" valign="middle" rowspan="1" colspan="1">Search terms</th>
    <th align="center" valign="middle" rowspan="1" colspan="1">Number of studies included</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">All cytotoxic 
     <break/>chemotherapy
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">(SARS-CoV-2 or coronavirus or COVID or betacoronavirus or Middle East Respiratory Syndrome Coronavirus (MERS-CoV) or SARS-CoV AND 
     <break/>chemotherapy)
    </td>
    <td align="center" valign="top" rowspan="1" colspan="1">24/30</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Low-dose steroids/NSAIDs</td>
    <td align="left" valign="top" rowspan="1" colspan="1">(SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) AND (anti-inflammatory or ibuprofen or isobutylphenylpropionic acid or cortisone or non-steroidal anti-inflammatory)</td>
    <td align="center" valign="top" rowspan="1" colspan="1">13/58</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Any TNF blocker</td>
    <td align="left" valign="top" rowspan="1" colspan="1">((SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) AND (TNF blocker or Anti-TNF therapy or TNFÎ± inhibitor or infliximab or etanercept or Certolizumab or Golimumab or adalimumab))</td>
    <td align="center" valign="top" rowspan="1" colspan="1">2/3</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">IL-6 blockade</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Two different search strategies were explored due to the number of agents that block the IL-6:
     <break/>((SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) AND (Anti-IL-6 therapy or anti-interleukin-6 receptor antibody or anti-interlukin-6 therapy or interlukin 6 blockage or interlukin-6 blockage or IL 6 blockage or IL-6 blockage or tocilizumab or siltuximab or Sylvant or sarilumab or olokizumab or CDP6038 or elsilimomab or BMS-945429 or ALD518 or sirukumab or CNTO 136 or CPSI-2364 or ALX-0061 or clazakizumab or olokizumab or sarilumab or sirukumab or ARGX-109 or FE301 or FM101)) 
     <break/>((SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) and (IL-6 or interlukin 6 or Anti-IL-6 therapy or IL-6 blockage or tocilizumab or siltuximab))
    </td>
    <td align="center" valign="top" rowspan="1" colspan="1">0
     <break/>23/108
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">JAK inhibitors</td>
    <td align="left" valign="top" rowspan="1" colspan="1">((SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) and (JAK or JAK1 or JAK2 or TYK3 or tofacitinib or baricitinib or filgotinib or peficitinib or ABT494 or decernotinib))</td>
    <td align="center" valign="top" rowspan="1" colspan="1">4/15</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">IL-1 blockade</td>
    <td align="left" valign="top" rowspan="1" colspan="1">(SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) AND (Interleukin-1 or IL-1 or IL-1RA or canakinumab or anti-IL-1 or IL-1 antagonists or IL-1 blockers or rilonacept or IL-1 trap or ACZ885 or anakinra)</td>
    <td align="center" valign="top" rowspan="1" colspan="1">9/37</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Mycophenylate</td>
    <td align="left" valign="top" rowspan="1" colspan="1">(SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) AND (mycophenolate mofetil OR mycophenolate OR myfortic)</td>
    <td align="center" valign="top" rowspan="1" colspan="1">13/29</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Tacrolimus</td>
    <td align="left" valign="top" rowspan="1" colspan="1">(SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) AND (envarsus or tacni or tacrolimus or prograf or FK506)</td>
    <td align="center" valign="top" rowspan="1" colspan="1">3/18</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Anti-CD20</td>
    <td align="left" valign="top" rowspan="1" colspan="1">((SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) AND (anti-cd20 monoclonal antibodies or anti-cd20 or rituximab or truxima or zevalin or ruxience or rituxan or arzerra or gazyva)</td>
    <td align="center" valign="top" rowspan="1" colspan="1">0</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">CTLA4-Ig</td>
    <td align="left" valign="top" rowspan="1" colspan="1">((SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV) AND (CTLA-4 Ig or CTLA4 or CTLA-4 or Ipilimumab or yervoy)</td>
    <td align="center" valign="top" rowspan="1" colspan="1">0</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
